The opioid crisis has become a significant public health concern, leading to an increased need for effective treatment options for individuals struggling with opioid use disorder. Among these options, two treatments have gained considerable attention: Sublocade and methadone. Both therapies aim to alleviate withdrawal symptoms and cravings, helping patients regain control of their lives. However, they differ in their formulations, administration methods, and overall effectiveness. Sublocade is a relatively newer medication that delivers buprenorphine in a long-acting injectable form. This novel delivery system allows for once-monthly administration, which can enhance adherence and reduce the risk of misuse. On the other hand, methadone has been a cornerstone of opioid addiction treatment…